about
Molecular weight dependence of the depletion attraction and its effects on the competitive adsorption of lung surfactant.Rediscovering the Schulze-Hardy rule in competitive adsorption to an air-water interfaceOvercoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability.Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimentalEnhanced surfactant adsorption via polymer depletion forces: a simple model for reversing surfactant inhibition in acute respiratory distress syndromeBench-to-bedside review: the role of glycosaminoglycans in respiratory disease.A freeze-fracture transmission electron microscopy and small angle x-ray diffraction study of the effects of albumin, serum, and polymers on clinical lung surfactant microstructure.New synthetic surfactants--basic science.Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometerMechanisms of polyelectrolyte enhanced surfactant adsorption at the air-water interface.Transient exposure of pulmonary surfactant to hyaluronan promotes structural and compositional transformations into a highly active state.The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.Pulmonary surfactant proteins and polymer combinations reduce surfactant inhibition by serum.Reductions of phospholipase A(2) inhibition of pulmonary surfactant with hyaluronan.Kinematic viscosity of therapeutic pulmonary surfactants with added polymers.Polyethylene glycol-surfactant for lavage lung injury in rats.Hyaluronan reduces surfactant inhibition and improves rat lung function after meconium injury.Effects of hyaluronan-fortified surfactant in ventilated premature piglets with respiratory distress.Chitosan enhances the in vitro surface activity of dilute lung surfactant preparations and resists albumin-induced inactivation.Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin
P2860
Q30484363-005FCBAC-3883-4F23-832F-6B96D027C562Q30489870-52BCD79A-909C-492F-B8CD-337CCCE38D03Q33712598-E579A240-7E0B-4B1D-A5EF-2DA5A3E4DFA1Q34351120-4E78B372-84BC-43EA-9B59-5883805E6E90Q35220151-4B828D63-215D-4C89-8CFC-4896E5538903Q35629808-DE5A25C8-A8D6-4DED-B07B-467A6AC6D813Q35881257-F861EC9D-75EA-4838-977D-5AD97E1B9EE5Q36178022-C5E55400-D906-45E3-B5AD-F570D94E4A1AQ36318031-AB2E4321-98E4-45FE-A252-BA9D141C19DFQ37181616-70095092-5AA0-42DA-8211-25A3F0D205DBQ37226241-2D1EADC1-2EC0-47D1-B4C8-0FA046F9F4B1Q37346515-4E58662D-6DE6-491D-AC18-223FE10E476FQ41843692-3E24C175-5F57-4285-86AB-F21CC8CAE6E5Q43119893-F84598F5-750B-487C-BC00-638D1FE3C145Q43143138-7674ED4D-C41E-415F-B93B-98BF93DCDF18Q46366325-980DE3D8-FEDC-4F81-A437-10412825A38AQ46417589-6DE7CB1B-C0EB-49E1-8A40-09B9CC22079BQ46697257-4ED808FA-4809-41FA-ACE2-83E63906380CQ51156720-3B6C7963-CDC0-4442-9A21-72DFD3D7973EQ58713589-ECD0A81D-2BB5-4627-935F-A7972373F28D
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Hyaluronan decreases surfactant inactivation in vitro.
@en
Hyaluronan decreases surfactant inactivation in vitro.
@nl
type
label
Hyaluronan decreases surfactant inactivation in vitro.
@en
Hyaluronan decreases surfactant inactivation in vitro.
@nl
prefLabel
Hyaluronan decreases surfactant inactivation in vitro.
@en
Hyaluronan decreases surfactant inactivation in vitro.
@nl
P2093
P2860
P1433
P1476
Hyaluronan decreases surfactant inactivation in vitro.
@en
P2093
H William Taeusch
John A Clements
Jon Goerke
Karen W Lu
P2860
P304
P356
10.1203/01.PDR.0000150726.75308.22
P407
P577
2004-12-07T00:00:00Z
P6179
1047212072